跳至主要内容
临床试验/NCT01644448
NCT01644448Unknown1 期

A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate Safety & Efficacy Of Autologous Human Platelet Lysate (HPL) for Treatment of Periorbital Hyperpigmentation (Dark Circles)

Kasiak Research Pvt. Ltd.2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
1 期
入组人数
20
试验地点
2
主要终点
Photographic Assessment

研究概览

简要总结

This is a multicentre, open label, randomized, pilot study to evalute safety and efficacy of Human Platelet Lysate (HPL) in subjects with Periorbital Hyperpigmentation. The study is being conducted at 2 centers in India.The primary endpoints are Physicians and Patient Self assessment score. The secondary endpoints are improvement in photographic assessment form randomization to end of study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects (male and female), aged 18 to 55 years (both inclusive) with Periorbital Hyperpigmentation.
  • Subject willing to refrain from any other treatment of Periorbital Hyperpigmentation during entire study duration.
  • Subjects who are willing to give informed consent and adhere to the study protocol.

排除标准

  • Subjects aged less than 18 and more than 55 years
  • Subjects with history of connective tissue disease.
  • Subjects with metabolic or hematopoietic disorders
  • Subjects unwilling to or unable to comply with the study protocol.
  • Subjects taking concomitant therapy that might interfere with the study results in the investigator's opinion or participating in another trial in the past 30 days.

结局指标

主要结局

Photographic Assessment

时间窗: Day 0, Month 1, Month 2, End of Study - 3 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

A Study to Determine the Safety & Efficacy of... | 临床试验